SPDR S&P Pharmaceuticals ETF
XPH
XPH
85 hedge funds and large institutions have $129M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
33% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 24
Holders
85
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.22M | |
| 2 | +$2.17M | |
| 3 | +$2.01M | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.92M |
| 5 |
VF
Virtu Financial
New York
|
+$1.07M |
Top Sellers
| 1 | -$17.8M | |
| 2 | -$7.53M | |
| 3 | -$5.43M | |
| 4 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
-$5.25M |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$4.25M |